Onconetix ONCO
NASDAQ ONCO
$0.65 -0.02 (-2.47%)
At close: Aug 21, 2026 · 4:00 PM EDT

Onconetix (ONCO) Return on Sales (2024 - 2026)

Onconetix (ONCO) posted quarterly Return on Sales of 0.19% for Q1 2026, up 66.0% year-over-year from 0.12% in Q1 2025, and down 130.29% quarter-over-quarter from 0.64% in Q4 2025.

Onconetix (ONCO) Return on Sales (2024 - 2026) Analysis & Trends

Onconetix (ONCO) has reported Return on Sales for 3 consecutive years, with 0.19% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Return on Sales rose 66.0% year-over-year to 0.19%; the TTM figure through Mar 2026 stood at 0.19% (down 21.0% YoY), while the FY2025 annual figure was 0.23%, down 23.0% from the prior year.
  • Return on Sales declined to 0.19% in Q1 2026 per ONCO's latest filing, from 0.64% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.64% in Q4 2025 and bottomed at 0.85% in Q1 2025.
  • Historically, Return on Sales has averaged 0.11% across 3 years, with a median of 0.19% in 2026.
  • Annual changes were most pronounced in 2025 — Return on Sales plunged 70 bps — and 2026, when it surged 66 bps.
  • Onconetix's Return on Sales stood at 0.4% in 2024, then soared by 59 bps to 0.64% in 2025, then plunged by 130 bps to 0.19% in 2026.
  • Business Quant data shows ONCO's Return on Sales at 0.19% in Q1 2026, 0.64% in Q4 2025, and 0.29% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.00%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 0.00%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.00%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.00%
10 Onconetix 1.44 Mn -4.50 Mn 4,303.00 -1.67%

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.67%
Mar 31, 2026 -0.19%
Dec 31, 2025 0.64%
Sep 30, 2025 -0.29%
Jun 30, 2025 -0.22%
Mar 31, 2025 -0.85%
Dec 31, 2024 0.40%
Sep 30, 2024 -0.10%
Jun 30, 2024 -0.20%
Mar 31, 2024 -0.16%